A simple case and a corresponding challenge were developed to teach the core criteria required to evaluate an R&D-focused biotechnology company from an investment perspective. Examination of the technology, the commercial opportunity and various financial aspects provides the basis for such an evaluation.
0 Comments
|
AuthorDuncan Jones Archives
June 2024
Categories |